Perigon Wealth Management’s Eli Lilly LLY Stock Holding History

Perigon Wealth Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Hold	0	–	–	–	917

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Perigon Wealth Management's LLY Position: Q2 2026 in Review

Perigon Wealth Management reduced its Eli Lilly (LLY) stake by 1.2% in Q2 2026, selling an estimated $478K and leaving 37,313 shares worth $44.8M. The position accounts for 0.7% of the portfolio, ranked #22.

Perigon Wealth Management first reported a position in LLY in Q2 2014 and has held it in 48 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Perigon Wealth Management held 37,313 shares of Eli Lilly worth $44.8M as of Q2 2026.
Perigon Wealth Management sold 468 Eli Lilly shares in Q2 2026, an estimated $478K.
Eli Lilly made up 0.7% of Perigon Wealth Management's portfolio in Q2 2026, its #22 holding.
Perigon Wealth Management first reported a position in Eli Lilly in Q2 2014 and has held it in 48 quarters since.
4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Perigon Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.